| Integrated genomic characterization of endometrial carcinoma DA Levine, ... Nature 497 (7447), 67-73, 2013 | 4815 | 2013 |
| Endogenous HMGB1 regulates autophagy D Tang, R Kang, KM Livesey, CW Cheh, A Farkas, P Loughran, G Hoppe, ... Journal of Cell Biology 190 (5), 881-892, 2010 | 1038 | 2010 |
| Induction of Th17 cells by segmented filamentous bacteria in the murine intestine AM Farkas, C Panea, Y Goto, G Nakato, M Galan-Diez, S Narushima, ... Journal of Immunological Methods 421, 104-111, 2015 | 625* | 2015 |
| The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival R Kang, D Tang, NE Schapiro, KM Livesey, A Farkas, P Loughran, ... Cell Death & Differentiation 17 (4), 666-676, 2010 | 377 | 2010 |
| Intestinal Monocyte-Derived Macrophages Control Commensal-Specific Th17 Responses C Panea, AM Farkas, Y Goto, S Abdollahi-Roodsaz, C Lee, B Koscso, ... Cell Reports 12, 1-11, 2015 | 148 | 2015 |
| Estrogen receptor β functions through nongenomic mechanisms in lung cancer cells GF Zhang, X Liu, AM Farkas, AV Parwani, KL Lathrop, D Lenzner, ... Molecular endocrinology 23 (2), 146-156, 2009 | 142 | 2009 |
| Fibroblast growth factor receptor 3 alterations and response to PD-1/PD-L1 blockade in patients with metastatic urothelial cancer L Wang, Y Gong, A Saci, PM Szabo, A Martini, A Necchi, A Siefker-Radtke, ... European urology 76 (5), 599-603, 2019 | 105 | 2019 |
| Myeloid cell–associated resistance to PD-1/PD-L1 blockade in urothelial cancer revealed through bulk and single-cell RNA sequencing L Wang, JP Sfakianos, KG Beaumont, G Akturk, A Horowitz, RP Sebra, ... Clinical Cancer Research 27 (15), 4287-4300, 2021 | 56 | 2021 |
| NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer B Salomé, JP Sfakianos, D Ranti, J Daza, C Bieber, A Charap, C Hammer, ... Cancer Cell 40 (9), 1027-1043. e9, 2022 | 49 | 2022 |
| Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration S Cascio, AM Farkas, RP Hughey, OJ Finn Oncotarget 4 (10), 1686, 2013 | 49 | 2013 |
| Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer JP Sfakianos, B Salome, J Daza, A Farkas, N Bhardwaj, A Horowitz Urologic Oncology: Seminars and Original Investigations 39 (2), 121-129, 2021 | 38 | 2021 |
| Vaccines based on abnormal self-antigens as tumor-associated antigens: immune regulation AM Farkas, OJ Finn Seminars in immunology 22 (3), 125-131, 2010 | 38 | 2010 |
| TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer MD Park, I Reyes-Torres, J LeBerichel, P Hamon, NM LaMarche, ... Nature immunology 24 (5), 792-801, 2023 | 35 | 2023 |
| Editorial overview Detecting DNA: Getting and begetting cancer AM Farkas, TM Kilgore, MT Lotze Current Opinion in Investigational Drugs 8 (12), 2007 | 34 | 2007 |
| Biological activities of cytokine‐neutralizing hyaluronic acid–antibody conjugates LT Sun, SA Bencherif, TW Gilbert, AM Farkas, MT Lotze, NR Washburn Wound repair and regeneration 18 (3), 302-310, 2010 | 24 | 2010 |
| Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer F Audenet, AM Farkas, H Anastos, MD Galsky, N Bhardwaj, JP Sfakianos World journal of urology 36, 1741-1748, 2018 | 18 | 2018 |
| Tim-3 and TIGIT mark Natural Killer cells susceptible to effector dysfunction in human bladder cancer AM Farkas, F Audenet, H Anastos, M Galsky, J Sfakianos, N Bhardwaj The Journal of Immunology 200 (1_Supplement), 124.14-124.14, 2018 | 13 | 2018 |
| TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer K Attalla, AM Farkas, H Anastos, F Audenet, MD Galsky, N Bhardwaj, ... Urologic Oncology: Seminars and Original Investigations 40 (9), 403-406, 2022 | 11 | 2022 |
| Antigen choice determines vaccine-induced generation of immunogenic versus tolerogenic dendritic cells that are marked by differential expression of pancreatic enzymes AM Farkas, DM Marvel, OJ Finn The Journal of Immunology 190 (7), 3319-3327, 2013 | 10 | 2013 |
| Harnessing natural killer cell function for genitourinary cancers N Bhardwaj, AM Farkas, Z Gul, JP Sfakianos Urologic Clinics of North America 47 (4), 433-442, 2020 | 9 | 2020 |
